annual CAPEX:
$1.90M-$7.57M(-79.93%)Summary
- As of today (September 11, 2025), CRSP annual capital expenditures is $1.90 million, with the most recent change of -$7.57 million (-79.93%) on December 31, 2024.
- During the last 3 years, CRSP annual CAPEX has fallen by -$79.80 million (-97.67%).
- CRSP annual CAPEX is now -97.67% below its all-time high of $81.70 million, reached on December 31, 2021.
Performance
CRSP CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$117.00K-$89.00K(-43.20%)Summary
- As of today (September 11, 2025), CRSP quarterly capital expenditures is $117.00 thousand, with the most recent change of -$89.00 thousand (-43.20%) on June 30, 2025.
- Over the past year, CRSP quarterly CAPEX has dropped by -$590.00 thousand (-83.45%).
- CRSP quarterly CAPEX is now -99.68% below its all-time high of $37.05 million, reached on September 30, 2021.
Performance
CRSP quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$796.00K-$590.00K(-42.57%)Summary
- As of today (September 11, 2025), CRSP TTM capital expenditures is $796.00 thousand, with the most recent change of -$590.00 thousand (-42.57%) on June 30, 2025.
- Over the past year, CRSP TTM CAPEX has dropped by -$3.49 million (-81.42%).
- CRSP TTM CAPEX is now -99.12% below its all-time high of $90.03 million, reached on March 31, 2022.
Performance
CRSP TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CRSP CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -79.9% | -83.5% | -81.4% |
| 3 y3 years | -97.7% | -98.8% | -98.9% |
| 5 y5 years | -71.6% | -96.8% | -92.0% |
CRSP CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.7% | at low | -98.8% | at low | -98.9% | at low |
| 5 y | 5-year | -97.7% | at low | -99.7% | at low | -99.1% | at low |
| alltime | all time | -97.7% | >+9999.0% | -99.7% | >+9999.0% | -99.1% | >+9999.0% |
CRSP CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $117.00K(-43.2%) | $796.00K(-42.6%) |
| Mar 2025 | - | $206.00K(-18.9%) | $1.39M(-27.1%) |
| Dec 2024 | $1.90M(-79.9%) | $254.00K(+16.0%) | $1.90M(-20.3%) |
| Sep 2024 | - | $219.00K(-69.0%) | $2.38M(-44.3%) |
| Jun 2024 | - | $707.00K(-1.9%) | $4.28M(-39.9%) |
| Mar 2024 | - | $721.00K(-2.3%) | $7.13M(-24.7%) |
| Dec 2023 | $9.47M(-74.5%) | $738.00K(-65.2%) | $9.47M(-36.5%) |
| Sep 2023 | - | $2.12M(-40.4%) | $14.92M(-20.7%) |
| Jun 2023 | - | $3.56M(+16.2%) | $18.82M(-24.4%) |
| Mar 2023 | - | $3.06M(-50.6%) | $24.90M(-33.1%) |
| Dec 2022 | $37.19M(-54.5%) | $6.19M(+2.9%) | $37.19M(-7.4%) |
| Sep 2022 | - | $6.02M(-37.5%) | $40.18M(-43.6%) |
| Jun 2022 | - | $9.63M(-37.3%) | $71.21M(-20.9%) |
| Mar 2022 | - | $15.35M(+67.2%) | $90.03M(+10.2%) |
| Dec 2021 | $81.70M(+345.1%) | $9.18M(-75.2%) | $81.70M(+3.7%) |
| Sep 2021 | - | $37.05M(+30.2%) | $78.76M(+66.7%) |
| Jun 2021 | - | $28.45M(+305.0%) | $47.23M(+111.0%) |
| Mar 2021 | - | $7.02M(+12.6%) | $22.39M(+22.0%) |
| Dec 2020 | $18.36M | $6.24M(+13.0%) | $18.36M(+40.4%) |
| Sep 2020 | - | $5.52M(+53.2%) | $13.07M(+30.6%) |
| Jun 2020 | - | $3.60M(+20.5%) | $10.01M(+16.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $2.99M(+214.2%) | $8.58M(+28.3%) |
| Dec 2019 | $6.68M(+141.0%) | $952.00K(-61.3%) | $6.68M(-0.7%) |
| Sep 2019 | - | $2.46M(+13.2%) | $6.73M(+35.6%) |
| Jun 2019 | - | $2.17M(+98.2%) | $4.97M(+49.8%) |
| Mar 2019 | - | $1.10M(+9.7%) | $3.31M(+19.5%) |
| Dec 2018 | $2.77M(-64.5%) | $1.00M(+43.9%) | $2.77M(+40.2%) |
| Sep 2018 | - | $695.00K(+32.9%) | $1.98M(-53.8%) |
| Jun 2018 | - | $523.00K(-5.8%) | $4.28M(-15.9%) |
| Mar 2018 | - | $555.00K(+170.7%) | $5.08M(-34.9%) |
| Dec 2017 | $7.81M(+159.1%) | $205.00K(-93.2%) | $7.81M(-0.3%) |
| Sep 2017 | - | $2.99M(+125.1%) | $7.84M(+23.4%) |
| Jun 2017 | - | $1.33M(-59.5%) | $6.35M(+4.7%) |
| Mar 2017 | - | $3.29M(+1340.8%) | $6.07M(+101.2%) |
| Dec 2016 | $3.02M(+161.4%) | $228.00K(-84.9%) | $3.02M(+8.2%) |
| Sep 2016 | - | $1.51M(+44.1%) | $2.79M(+118.0%) |
| Jun 2016 | - | $1.05M(+351.3%) | $1.28M(+282.9%) |
| Mar 2016 | - | $232.00K(+127.5%) | $334.00K(+227.5%) |
| Dec 2015 | $1.15M(>+9900.0%) | - | - |
| Jun 2015 | - | $102.00K(>+9900.0%) | $102.00K(>+9900.0%) |
| Mar 2015 | - | $0.00 | $0.00 |
| Dec 2014 | $0.00 | - | - |
FAQ
- What is CRISPR Therapeutics AG annual capital expenditures?
- What is the all time high annual CAPEX for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual CAPEX year-on-year change?
- What is CRISPR Therapeutics AG quarterly capital expenditures?
- What is the all time high quarterly CAPEX for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly CAPEX year-on-year change?
- What is CRISPR Therapeutics AG TTM capital expenditures?
- What is the all time high TTM CAPEX for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM CAPEX year-on-year change?
What is CRISPR Therapeutics AG annual capital expenditures?
The current annual CAPEX of CRSP is $1.90M
What is the all time high annual CAPEX for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual capital expenditures is $81.70M
What is CRISPR Therapeutics AG annual CAPEX year-on-year change?
Over the past year, CRSP annual capital expenditures has changed by -$7.57M (-79.93%)
What is CRISPR Therapeutics AG quarterly capital expenditures?
The current quarterly CAPEX of CRSP is $117.00K
What is the all time high quarterly CAPEX for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly capital expenditures is $37.05M
What is CRISPR Therapeutics AG quarterly CAPEX year-on-year change?
Over the past year, CRSP quarterly capital expenditures has changed by -$590.00K (-83.45%)
What is CRISPR Therapeutics AG TTM capital expenditures?
The current TTM CAPEX of CRSP is $796.00K
What is the all time high TTM CAPEX for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM capital expenditures is $90.03M
What is CRISPR Therapeutics AG TTM CAPEX year-on-year change?
Over the past year, CRSP TTM capital expenditures has changed by -$3.49M (-81.42%)